Study of High-definition Transcranial Infraslow Gray Noise Stimulation to Treat Chronic Low Back Pain in Adults Aged 18 to 75
Led by University of Otago · Updated on 2025-07-31
164
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the use of a non-invasive brain stimulation technique called High-definition Transcranial Infraslow Gray Noise Stimulation HD-tIGNS in adults with chronic low back pain. This randomized, double-blind clinical trial aims to assess how well this brain stimulation improves pain intensity, its safety, possible side effects, and participants perceptions of the treatment process. The study is led by the University of Otago and includes adults aged 18 to 75 years who have experienced lower back pain for at least half the days in the past six months.
Participants will be randomly assigned to either an active brain stimulation group or a sham placebo stimulation group. Both groups will receive 12 sessions over four weeks, with three one-hour sessions per week. The active group will receive 30 minutes of HD-tIGNS per session, with specific electrode placements delivering targeted brain stimulation, while the sham group will experience brief initial sensations mimicking the active treatment without ongoing stimulation to maintain blinding.
Throughout the study, participants will undergo assessments at the start, immediately after treatment completion, and at one, three, and six months post-treatment. These evaluations include measuring pain intensity, pain interference, movement-evoked pain, functional abilities, quality of life, mental health factors, and brain activity using EEG and cognitive tasks. Researchers will also monitor safety, side effects, and participants experiences with the treatment and study procedures, with total participation lasting over six months.
CONDITIONS
Brief Title
Brain Network Stimulation for Chronic Low Back Pain.
Research Team
D
Divya Adhia, Ph.D
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Dunedin School of Medicine, University of Otago, Dunedin, New Zealand
Collaborating Sponsor
Who Can Participate
Age: 18Years - 75Years
All Genders
Eligibility Criteria
You may qualify if you...
Age between 18 to 75 years on the day of screening
Pain in the lower back (region between 12th rib and gluteal fold) with or without leg pain occurring at least half the days in the last six months
Average pain intensity of 4 or higher on the 11-point Numeric Pain Rating Scale in the week before enrollment
Disability score of 5 or higher on the Roland-Morris Disability Questionnaire
You will not qualify if you...
Known or suspected serious spinal pathology such as fracture, lumbar canal stenosis, malignant, inflammatory or infectious spine diseases, cauda equina syndrome, or widespread neurological disorder
Suspected or confirmed pregnancy or less than six months postpartum
Inflammatory or autoimmune disorders
Recent soft tissue injuries of the back within the last 3 months
Recent steroid injections to the back within the last 3 months
Recent spinal surgery within the past 12 months or scheduled major surgery during treatment or follow-up
History of neurological or psychiatric disorders (except depression and anxiety)
History of cancer or current cancer treatment
Cognitive impairments indicated by a Mini-Mental State Examination score of 24 or below
Alcohol or substance abuse
History of epilepsy or seizures
Presence of electronic implants (e.g., pacemaker), metal implants in head or neck, or spinal cord stimulator
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
screening and enrollment visit
Implementation
Duration - 4 weeks
Participants receive high-definition transcranial infraslow gray noise stimulation or sham stimulation to target brain networks related to chronic low back pain.
Three sessions per week, 30 minutes per session, for a total of 12 sessions
Follow-up
Duration - 6 months
Participants are monitored to assess changes in pain intensity, pain interference, function, and other health outcomes after treatment completion.
Visits at 1 week, 1 month, 3 months, and 6 months post treatment completion
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Evaluating MuscleSCS Device for Treating Chronic Low Back Pain in Adults
Evaluating Two Types of Lumbar Radiofrequency Ablation Compared to a Simulated Procedure for Chronic Low Back Pain
Study of Immediate Effects of Isometric Exercises on Pain Sensitivity and Intensity in Adults with Chronic Low Back Pain
Pilot Study of Supervised Group Art Therapy Combined With Exercise for Adults 18 to 59 With Chronic Low Back Pain
Comparing Neuromodulation Plus PRP Therapy to Conventional Treatment for Chronic Low Back Pain in Adults Aged 40 to 60
Study of Bone Marrow Aspirate Concentrate Injection During Lumbar Microdiscectomy Surgery in Adults with Lumbar Disc Herniation
Study of High-definition Transcranial Infraslow Gray Noise Stimulation to Treat Chronic Low Back Pain in Adults Aged 18 to 75
Zoom-Based Brief Pain Exposure Therapy for Adults with Fibromyalgia, Lupus, Chronic Pelvic Pain, or Chronic Low Back Pain
Testing Osteopathic Manipulative Treatment Added to Usual VA Care for Veterans with Chronic Low Back Pain
Study Comparing JHG002 Pharmacopuncture and Physical Therapy for Adults with Chronic Low Back Pain